Financial Instruments - Schedule of Non-Marketable Equity Securities (Details) - USD ($) $ in Millions |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Fair Value Disclosures [Abstract] | ||
| Initial cost basis | $ 3,124 | $ 2,673 |
| Upward adjustments | 3,757 | 3,726 |
| Downward adjustments (including impairment) | (3,069) | (2,002) |
| Total carrying value at the end of the period | $ 3,812 | $ 4,397 |
| X | ||||||||||
- Definition Equity Securities Without Readily Determinable Fair Value, Cost Basis, Cumulative Amount No definition available.
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|